Novel Targeted Therapies for the Treatment of Multiple Myeloma

Objectives
Examines and discusses the advancement of innovative, targeted therapies for the treatment of myeloma.

Chairs
Kenneth C. Anderson, MD
Director, Jerome Lipper Multiple Myeloma Center
Medical Director, Kraft Family Donor Center
Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute

Mario Boccadoro, MD
Professor of Medicine
Director, Section of Hematology
University of Torino

Sponsors
Celgene Corporation
Millennium Pharmaceuticals
Novartis Pharmaceuticals Corporation
McCarty Cancer Foundation
Ortho Biotech

Download Abstracts